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Introduction
Liver transplantation is widely used as a treatment for
end-stage liver disease. Liver allografts seem privileged
compared with other solid organ grafts for a number of
reasons. Successful liver transplantation can be performed
across major histocompatibility complex (MHC) dispari-
ties, and the liver is the only solid organ that, when trans-
planted, can protect other co-transplanted syngeneic
organs from immunological tissue destruction [1]. A pro-
portion of patients with stable function can have immu-
nosuppression reduced or withdrawn completely [2,3].
The reasons for this "liver effect" are not understood.
Recently, there has been interest in lymphocyte apoptosis
that occurs in OLT animal models. Allograft tolerance can
be readily induced in experimental animals, particularly
rodents, and spontaneous tolerance of mismatched liver
grafts occurs in some train combinations [4]. In a sponta-
neously tolerant murine model of liver transplantation,
the development of tolerance was associated with a higher
rate of apoptosis of cells in the portal inflammatory infil-
trate [5]. Sharland et al. [6], in a rat model, also showed
that tolerant animals had higher numbers of apoptotic
cells; they demonstrated by double staining that these
were T lymphocytes.
Kupffer cells (KC), the resident macrophage population in
the liver, are found within the sinusoidal lumen, adhering
to the liver sinusoidal endothelial cells (LSEC). KC, which
comprise one of major populations (20%) of the hepatic
nonparenchymal cell fraction (NPC), can directly interact
with passenger leukocytes and thus may play a role in
immunomodulation and the induction of tolerance [7].
Following liver transplantation, donor KC not only
migrate into the recipient lymph nodes, but also can be
quickly replaced by recipient-derived monocytes [8,9].
Thus, KC are uniquely positioned for regulation of the T
cell response in the liver. Our previous studies have
shown that KC play an immunomodulatory role as man-
ifested by inhibiting T lymphocyte proliferation in
response to alloantigen stimulation. The purpose of this
study was to quantify the effects of liver transplantation
on KC immunomodulatory function, focusing specifically
on Fas ligand (FasL) expression and their role in allo-reac-




Male Lewis (RT11), and DA (RT1ab) rats were purchased
from Harlan Sprague-Dawley (Indianapolis, IN) and used
at 8–12 wk of age. Animals were maintained in the spe-
cific pathogen-free facility of Johns Hopkins Medical
Institutions. Animals were cared for according to NIH
guidelines and under a protocol approved by the Johns
Hopkins University Animal Care Committee.
Orthotopic liver transplantation
Orthotopic liver transplantation (OLT) was performed
under methoxyflurane (Medical Development,
Springvale, Australia) inhalation anesthesia, according to
a method modified from that described by Kamada and
Calne [10]. The hepatic artery was not reconstructed.
Three combinations were selected: 1) a model of chronic
allograft acceptance (Lewis into DA, OLTR); 2) a model of
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acute allograft rejection (DA into Lewis, OLTA); and 3) a
model of syngeneic OLT (Lewis into Lewis, OLTS). Allo-
graft survival was determined by recipient survival and
rejection was confirmed histologically.
Lymphocyte preparation and Allo-reactive T cells 
activation
Suspensions of spleen cells (SC) were prepared by passage
of mechanically disunited spleens through a 50 microme-
ter stainless steel screen, erythrocyte lysis with tris-ammo-
nium chloride, and three washings in RPMI 1640 (1200
rpm for 5 min). From these SC suspension, T-lym-
phocytes and APCs were further purified by sequential
passage over nylon wool columns. Allo-reactive T cells
(ATC) were generated by incubation of either Lewis T cells
with γ-irradiated DA-APCs (2200 rads) or DA T cells with
irradiated Lewis-APCs for 5 days.
KC isolation
KC isolation was performed by 0.05% collagenase per-
fusion of the liver, isopycnic sedimentation in two-step
Percoll gradient (25% and 50% Percoll), and selective
adherence of the cell to plastic flasks [11,12]. This tech-
nique of cell isolation yielded, on average, 40 to 60 mil-
lion KC per liver, with 90–95% viability as determined by
trypan blue exclusion. The cells showed typical macro-
phage morphologic features and stained positively for
nonspecific esterase and both ED1 and ED2, and phago-
cytosed 1 micrometer Latex beads. In addition, these cells
express the Kupffer cell receptor (KCR) confirmed using
RT-PCR. Purity of the KC fraction was consistently >95%.
Quantitative RT-PCR for Fas ligand mRNA expression
To assess FasL mRNA expression, total RNA was subjected
to RT-PCR using the following primers: 5'-ATGCAG-
CAGCCCATG-3' and 5'-AAGCTTATACAAGCCGAA-3'.
Primers for beta-actin were purchased from Clontech
(Palo Alto, CA).
Western blots
KC proteins were extracted and whole cell extracts were
subjected to 12% SDS-PAGE. Resolved proteins were
transferred to a nitrocellulose membrane and incubated
with anti-FasL antibody (clone 33, BD PharMingen), and
followed with HRP-conjugated secondary antibody
(1:1000). After three 10-min washes with PBS-Tween 20,
Peroxidase activity was visualized with the ECL kit (Amer-
sham Pharmacia Biotech, Piscataway, NJ) according to the
manufacturer's instruction.
Cytotoxicity of KCs against allo-reactive T cells (ATC)
ATC were cultured with 3H-thymidine (5 µCi/ml) for 12
hours. 3H-thymidine labeled ATCs (1 × 105 cells/well) and
KC were co-cultured in 96 well plate at different E:T ratios
starting at 1:1 in 200 microliters of complete medium for
4 hours. Cells were harvested and thymidine release was
calculated as follows: % thymidine release = [cpm (with-
out effectors)-cpm (with effectors) / cpm (without effec-
tors)] × 100.
Inhibitory effect of anti-FasL antibody on cytotoxicity of 
KCs
To test the role of FasL in the cytotoxicity of KCs against
ATC, we measured 3H-thymidine release in a KC and ATC
co-culture system pulsed with the anti-FasL antibody or a
control IgG (BD PharMingen) at antibodies concentration
0.3 – 10 micrograms/ml.
Results
KC express FasL. In acceptance and rejection liver trans-
plant models, we measured KC FasL mRNA and protein
using RT-PCR and Western blotting, respectively. On post
transplantation days 3, 7 and 12, FasL mRNA expression
of KC recovered from the acceptance model was signifi-
cantly higher than that measured from KC recovered from
rejecting allografts (Fig. 1). FasL protein was also higher in
the acceptance model than that in rejection model, with
peak levels noted on day 7 following liver transplantation
(Fig. 2).
FasL mRNA expression of KC post-OLT determined by RT- PCR Figure 1
FasL mRNA expression of KC post-OLT determined by RT-
PCR.
FasL protein in KC post-OLT quantified using Western blot Figure 2
FasL protein in KC post-OLT quantified using Western blot.Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/S1/S32
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Cytotoxicity of KC against ATC dependent on FasL expres-
sion. Since activated T cells express elevated level of Fas,
we then determined the cytotoxicity of KC against allore-
active T cells (ATC). Coculture of ATC with non-trans-
planted Lewis or DA KC resulted in increased T cell lysis
compared to controls. KC recovered from either trans-
plant model had an increased ability to lyse ATC com-
pared with non-transplanted controls. Furthermore, KC
recovered from the acceptance model had a greater ability
to lyse ATC than KC from the rejection model seven days
post-transplantation. However, this lysis was significantly
suppressed by the addition of neutralizing anti-FasL anti-
body (Fig. 3).
Discussion
We have demonstrated that KC induced apoptosis and
lysis of allo-reactive T cells, and this lysis effect was inhib-
ited by anti-FasL antibody. KC FasL expression is
increased following liver transplantation and associated
with increased ability of KC lyses ATC. These observations
are consistent with the hypothesis that KC act as FasL-
expressing APCs, and may have the ability to induce and
maintain immune tolerance. Our results in this study give
rise to supplementary evidence that KC induce activated T
cells apoptosis; thus KC may participate in the develop-
ment of immune tolerance following allogeneic liver
transplantation.
Apoptosis of T cells mediated by FasL in a paracrine fash-
ion has been shown previously to be critical for the main-
tenance of the immunoprivileged site [13,14]. A recent
study suggests that the maintenance of immunoprivilege
involves the induction of systemic T cell tolerance [15].
Induction of Ag-specific T cell tolerance by FasL-trans-
fected APCs suggests a novel strategy for modulating the T
cell response [16]. Regulation of FasL expression in KC or
macrophages has been achieved in a number of experi-
ments. IFN-gamma induced overexpression of FasL in KC
has been proposed as a mechanism of hepatic immu-
noregulation [17]. Replacement of donor KC by recipient-
derived KC following OLT may also influence the FasL
expression of KC in liver allografts. For example, FasL
expression is higher in DA rat KC than in Lewis rat KC.
Donor Lewis hepatic KC replacement by recipient DA KC
following liver transplantation results in increased FasL
expression by KC in the liver allografts. Whether a genetic
difference in KC FasL expression contributes to allograft
acceptance in this model remains to be elucidated.
In conclusion, our findings identify an immunoregulatory
mechanism by which KC induce T cell apoptosis via Fas/
FasL pathway. This immunoregulatory ability of KC is dra-
matically increased following liver transplantation, espe-
cially in KC recovered from chronically accepted liver
allografts. These findings support our hypothesis that KC-
dependent T cell deletion via the Fas/FasL pathway may
play an important role in the induction of immune toler-
ance following liver transplantation.
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